Equity Overview
Price & Market Data
Price: $1.89
Daily Change: -$0.10 / 5.29%
Range: $1.75 - $2.01
Market Cap: $6,981,175
Volume: 115,884
Performance Metrics
1 Week: -11.81%
1 Month: -19.21%
3 Months: -58.08%
6 Months: -69.50%
1 Year: -93.07%
YTD: -57.64%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country: Germany
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.